Latin AmericaPolicy & Markets Brazil’s Private-Health Duopoly Splits: Rede D’Or Surges as Hapvida’s Verticalization Stumbles Same bet, opposite outcomes: Rede D’Or’s insurer-hospital machine compounds while Hapvida’s verticalization buckles under claims, losses and member cuts. By HealthSignals Editorial09/14/20264 Comments
Novo Nordisk Faces Generic Pressure as Chile Spends Nearly US$100M a Year on Weight-Loss Drugs 09/28/2026
You must be logged in to post a comment.